Castle Biosciences Ownership | Who Owns Castle Biosciences?
Castle Biosciences Ownership Summary
Castle Biosciences is owned by 91.76% institutional investors, 3.16% insiders, and 5.08% retail investors. Blackrock is the largest institutional shareholder, holding 11.08% of CSTL shares. Bellevue Healthcare Ord is the top mutual fund, with 4.32% of its assets in Castle Biosciences shares.
CSTL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Castle Biosciences | 91.76% | 3.16% | 5.08% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Diagnostics & Research Stocks | 57.60% | 10.69% | 31.72% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 3.04M | 11.08% | $66.29M |
Blackrock funding, inc. /de | 3.15M | 10.91% | $64.42M |
Vanguard group | 1.83M | 6.58% | $48.84M |
Principal financial group | 1.44M | 5.16% | $38.26M |
Portolan capital management | 1.49M | 5.15% | $30.42M |
Wasatch advisors lp | 1.05M | 3.63% | $21.44M |
Dimensional fund advisors lp | 999.47K | 3.59% | $26.64M |
Ubs group | 812.60K | 2.92% | $21.66M |
Braidwell lp | 822.74K | 2.85% | $16.80M |
Wellington management group llp | 722.12K | 2.59% | $19.24M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Birchview capital, lp | 110.60K | 2.24% | $2.26M |
Portolan capital management | 1.49M | 1.91% | $30.42M |
Parkman healthcare partners | 352.26K | 0.83% | $7.19M |
Perkins capital management | 28.00K | 0.57% | $571.66K |
Braidwell lp | 822.74K | 0.57% | $16.80M |
Palisade capital management, lp | 575.12K | 0.33% | $11.74M |
Alpha dna investment management | 15.17K | 0.15% | $404.39K |
Kornitzer capital management inc /ks | 278.31K | 0.11% | $5.68M |
Wasatch advisors lp | 1.05M | 0.11% | $21.44M |
Advantage alpha capital partners lp | 16.02K | 0.09% | $327.15K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ubs group | 812.60K | 0.00% | 758.47K |
Wellington management group llp | 722.12K | 0.00% | 722.12K |
Braidwell lp | 822.74K | 0.57% | 457.49K |
Blackrock | 3.04M | 0.00% | 449.29K |
Millennium management | 548.81K | 0.01% | 408.27K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Park west asset management | - | - | -556.49K |
Morgan stanley | 249.38K | 0.00% | -401.33K |
Bellevue group | - | - | -301.10K |
Soleus capital management | - | - | -252.92K |
Cubist systematic strategies | - | - | -237.70K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Wellington management group llp | 722.12K | 0.00% | 722.12K | $19.24M |
Bnp paribas arbitrage, snc | 249.13K | 0.00% | 249.13K | $6.64M |
D. e. shaw | 90.56K | 0.00% | 90.56K | $2.41M |
Empowered funds | 40.75K | 0.01% | 40.75K | $832.12K |
Aqr capital management | 21.11K | 0.00% | 21.11K | $562.72K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -1.00 |
National bank of canada /fi/ | -1.00 |
Colonial trust advisors | -6.00 |
Larson financial group | -12.00 |
Fairman group | -13.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 151 | -17.03% | 26,530,454 | 2.55% | 91 | 1.12% | 85 | -19.81% | 44 | -18.52% |
Mar 31, 2025 | 178 | -13.17% | 25,557,223 | -3.26% | 89 | 0.99% | 105 | -2.78% | 53 | -19.70% |
Dec 31, 2024 | 202 | 3.59% | 26,322,033 | 2.20% | 94 | 1.10% | 106 | -11.67% | 65 | 38.30% |
Sep 30, 2024 | 195 | 18.90% | 25,754,395 | 2.29% | 92 | 1.12% | 119 | 38.37% | 48 | -4.00% |
Jun 30, 2024 | 163 | 7.24% | 25,178,603 | 0.98% | 91 | 1.08% | 85 | 18.06% | 50 | -7.41% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Bellevue Healthcare Ord | 1.20M | 4.32% | 1.20M |
Vanguard US Total Market Shares ETF | 829.40K | 2.96% | - |
Principal SmallCap R5 | 829.94K | 2.86% | 78.59K |
Vanguard Total Stock Mkt Idx Inv | 826.46K | 2.85% | -18.32K |
Principal U.S. Small Cap Equity | 781.42K | 2.71% | 159.12K |
Strategic Advisers U.S. Total Stock | 729.16K | 2.53% | -52.62K |
Strategic Advisers U.S. Total Stock{mg} | 693.06K | 2.47% | - |
Wasatch Small Cap Growth Investor | 675.19K | 2.41% | -14.34K |
Strategic Advisers Small-Mid Cap | 665.91K | 2.40% | 62.85K |
iShares Russell 2000 ETF | 676.91K | 2.33% | -12.91K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 15, 2025 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Sell | $26.83K |
Aug 13, 2025 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Sell | $839.04K |
Jun 27, 2025 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Sell | $140.56K |
Jun 27, 2025 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Sell | $13.40K |
Jun 27, 2025 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Sell | $13.40K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 1 |
2025 Q2 | - | 20 |
2025 Q1 | - | 61 |
2024 Q4 | - | 64 |
2024 Q3 | - | 55 |
CSTL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools